Many people, even in Chicago, don't know about Rosalind Franklin University. It's probably the least well-known of Chicagoland's 6 medical schools. But nestled in the northern suburbs of Chicago, it sits close to Illinois huge cluster of biotech and pharmaceutical companies. Abbott, Baxter, Astellas, and Abbvie are the largest. But there are many smaller companies, as well as divisions of several other large healthcare companies.
Hoping to spur university-industry collaboration on new concepts and products, Rosalind Franklin in just 4 short years built a new science park. The park includes a new healthcare incubator, called Helix 51.
Michael Rosen, Managing Director of Research and Innovation at the University also heads up Helix 51. He joined The Savvy Entrepreneur Radio Show recently to discuss some of the challenges and opportunities of building a new incubator. He explains the difference between an accelerator and an incubator. He also talks about how the University is planning to expand shared services for incubator companies.
Click on the arrow to listen!
Podcast: Play in new window | Download